Genesis Healthcare (GEN) Reaches $2.63 After 7.00% Up Move; Shell Midstream Partners LP (SHLX) Had 5 Analysts Last Week

The stock of Genesis Healthcare Inc (NYSE:GEN) is a huge mover today! About 98,307 shares traded. Genesis Healthcare Inc (NYSE:GEN) has declined 8.09% since September 23, 2016 and is downtrending. It has underperformed by 18.42% the S&P500.The move comes after 9 months positive chart setup for the $419.85 million company. It was reported on May, 2 by Barchart.com. We have $2.81 PT which if reached, will make NYSE:GEN worth $29.39 million more.

Among 7 analysts covering Shell Midstream Partners (NYSE:SHLX), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Shell Midstream Partners had 10 analyst reports since July 2, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital with “Overweight” on Thursday, July 2. The stock of Shell Midstream Partners LP (NYSE:SHLX) has “Overweight” rating given on Wednesday, February 1 by JP Morgan. The firm earned “Buy” rating on Friday, September 30 by Mizuho. The stock has “Outperform” rating by RBC Capital Markets on Monday, May 2. The stock has “Equal-Weight” rating by Morgan Stanley on Thursday, June 16. The stock of Shell Midstream Partners LP (NYSE:SHLX) earned “Buy” rating by Evercore on Monday, November 30. The stock of Shell Midstream Partners LP (NYSE:SHLX) earned “Equal Weight” rating by Barclays Capital on Thursday, November 10. The company was maintained on Wednesday, November 9 by RBC Capital Markets. The rating was initiated by Stifel Nicolaus with “Buy” on Thursday, August 18. See Shell Midstream Partners LP (NYSE:SHLX) latest ratings:

01/02/2017 Broker: JP Morgan Rating: Overweight Initiate
10/11/2016 Broker: Barclays Capital Old Rating: Overweight New Rating: Equal Weight Old Target: $39 New Target: $29 Downgrade
09/11/2016 Broker: RBC Capital Markets Rating: Outperform Old Target: $47 New Target: $41 Maintain

Among 4 analysts covering Genesis Healthcare (NYSE:GEN), 0 have Buy rating, 2 Sell and 2 Hold. Therefore 0 are positive. Genesis Healthcare had 9 analyst reports since August 10, 2015 according to SRatingsIntel. On Monday, May 16 the stock rating was maintained by RBC Capital Markets with “Outperform”. RBC Capital Markets maintained it with “Outperform” rating and $5 target in Tuesday, January 26 report. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, November 21. On Monday, August 10 the stock rating was upgraded by RBC Capital Markets to “Sector Perform”. The stock of Genesis Healthcare Inc (NYSE:GEN) has “Neutral” rating given on Tuesday, January 26 by Bank of America. Susquehanna maintained it with “Neutral” rating and $2.75 target in Tuesday, January 26 report. The rating was downgraded by Bank of America on Monday, May 16 to “Underperform”. UBS maintained Genesis Healthcare Inc (NYSE:GEN) rating on Monday, November 9. UBS has “Neutral” rating and $5.50 target. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Sell” rating by UBS on Monday, February 8.

Genesis Healthcare, Inc. is a holding firm that provides post-acute care. The company has market cap of $419.85 million. The Firm operates through three divisions: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. It currently has negative earnings. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities.

Analysts await Genesis Healthcare Inc (NYSE:GEN) to report earnings on May, 8. They expect $-0.25 EPS, down 2,400.00% or $0.24 from last year’s $-0.01 per share.

About 166,666 shares traded. Shell Midstream Partners LP (NYSE:SHLX) has risen 3.83% since September 23, 2016 and is uptrending. It has underperformed by 6.51% the S&P500.

Shell Midstream Partners, L.P. is a master limited partnership company, which owns, operates, develops and acquires pipelines and other midstream assets. The company has market cap of $5.84 billion. The Firm conducts its activities through its subsidiary, Shell Midstream Operating, LLC. It has a 25.08 P/E ratio. The Company’s assets consist of interests in entities that own crude oil and refined products pipelines serving as key infrastructure to transport onshore and offshore crude oil production to Gulf Coast and Midwest refining markets and to deliver refined products from those markets to demand centers.